An Overview of Pharmaceutical Care in Type II Diabetes Mellitus
Patients: Current Position and Prospects

Kumutha      Theivasigamani; Senthilkumar      Palaniappan
Abstract

Diabetes mellitus is an ongoing disease that is related to a high mortality rate due to severe complications. Diabetes mellitus type 2 (DMT2) is a persistent metabolic deficiency and its prevalence has been increasing consistently worldwide. As a result, it is rapidly turning into a plague in some parts of the world, and the number of people affected is expected to double in the following decade due to an increase in the maturing populace, adding to the overall existing importance for medical service providers, particularly in the underdeveloped nations. Extensive diabetes care is an intricate task that takes a whole group of medical care experts, including drug specialists, to provide multidisciplinary care for the patients. The duty of drug experts has changed significantly in recent years, changing from conventional drug dispensing in the drug store to patient- centered clinical support services. Upgrading the medication treatment to accomplish better remedial results without causing drug-related issues has been considered the essential objective of treatment for diabetic patients. This review discusses the healthcare needs of patients with T2DM, the current evidence for the role of pharmacists in diabetes care, and insight into the upcoming role of pharmacists in its management. The advanced role of clinical pharmacists in diabetes control through drug treatment, diabetes care centers, and diabetes health counselor schooling, is also discussed in this review.
Keywords: Clinical pharmacist, diabetes mellitus, drug-related problems, pharmaceutical care, pharmacist intervention, treatment.
[1]
Lum ZK, Siaw MYL, Lee MJX, et al. Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes. Qual Life Res  2019; 28(12): 3273-9.
 [http://dx.doi.org/10.1007/s11136-019-02253-2] [PMID:  31359238]

[2]
Pousinho S, Morgado M, Plácido AI, Roque F, Falcão A, Alves G. Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharm Pract  2020; 18(3): 2000.
 [http://dx.doi.org/10.18549/PharmPract.2020.3.2000] [PMID:  32922572]

[3]
Ji H, Godsland I, Oliver NS, Hill NE. Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes. PLoS One  2020; 15(6): e0234319.
 [http://dx.doi.org/10.1371/journal.pone.0234319] [PMID:  32542057]

[4]
Arifin B, Idrus LR, van Asselt ADI, et al. Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Qual Life Res  2019; 28(5): 1179-90.
 [http://dx.doi.org/10.1007/s11136-019-02105-z] [PMID:  30649698]

[5]
Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm  2019; 15(9): 1057-67.
 [http://dx.doi.org/10.1016/j.sapharm.2018.09.021] [PMID:  30685443]

[6]
Nogueira M, Otuyama LJ, Rocha PA, Pinto VB. Pharmaceutical care-based interventions in type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials. Einstein  2020; 18: eRW4686.
 [http://dx.doi.org/10.31744/einstein_journal/2020RW4686] [PMID:  32022107]

[7]
Kumar VV, Reddy AH, Sudharshan J, Lokendranath G, RE Ugandar U, Chetty CM. A study on impact of pharmacist interventions on therapeutic outcomes of type II diabetic patients in a tertiary care teaching hospital. Indian J Pharm Pract  2020; 13(3): 259-65.
 [http://dx.doi.org/10.5530/ijopp.13.3.42]

[8]
Afaya RA, Bam V, Azongo TB, et al. Medication adherence and self-care behaviours among patients with type 2 diabetes mellitus in Ghana. PLoS One  2020; 15(8): e0237710.
 [http://dx.doi.org/10.1371/journal.pone.0237710] [PMID:  32822381]

[9]
Sharp LK, Tilton JJ, Touchette DR, et al. Community health workers supporting clinical pharmacists in diabetes management: A randomized controlled trial. Pharmacotherapy  2018; 38(1): 58-68.
 [http://dx.doi.org/10.1002/phar.2058] [PMID:  29121408]

[10]
Durrer C, McKelvey S, Singer J, et al. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: The Pharm-TCR randomized controlled trial protocol. Trials  2019; 20(1): 781.
 [http://dx.doi.org/10.1186/s13063-019-3873-7] [PMID:  31881991]

[11]
Hughes J, Wibowo Y, Sunderland B, Hoti K. The role of the pharmacist in the management of type 2 diabetes: Current insights and future directions. Integr Pharm Res Pract  2017; 6: 15-27.
 [http://dx.doi.org/10.2147/IPRP.S103783] [PMID:  29354547]

[12]
Geurts MME, Stewart RE, Brouwers JRBJ, de Graeff PA, de Gier JJ. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. Int J Clin Pharm  2016; 38(4): 808-15.
 [http://dx.doi.org/10.1007/s11096-016-0281-x] [PMID:  27052212]

[13]
Spinewine A, Evrard P, Hughes C. Interventions to optimize medication use in nursing homes: A narrative review. Eur Geriatr Med  2021; 12(3): 551-67.
 [http://dx.doi.org/10.1007/s41999-021-00477-5] [PMID:  33751478]

[14]
Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes  2016; 7(17): 354-95.
 [http://dx.doi.org/10.4239/wjd.v7.i17.354] [PMID:  27660695]

[15]
Zyoud SH, Al-Jabi SW, Sweileh WM, et al. Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: Findings from a cross-sectional study. J Clin Transl Endocrinol  2015; 2(2): 66-71.
 [http://dx.doi.org/10.1016/j.jcte.2015.03.002] [PMID:  29159112]

[16]
Erku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG. The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract  2017; 15(3): 1026.
 [http://dx.doi.org/10.18549/PharmPract.2017.03.1026] [PMID:  28943985]

[17]
Mouhtadi BB, Alame MM, Malaeb B, Hallit S, Salameh P, Malaeb D. Physician-community pharmacist collaborative care in diabetes management: A pilot study. J Drug Assess  2018; 7(1): 61-5.
 [http://dx.doi.org/10.1080/21556660.2018.1535437] [PMID:  30370175]

[18]
Alshayban D, Joseph R. Health-related quality of life among patients with type 2 diabetes mellitus in Eastern province, Saudi Arabia: A cross-sectional study. PLoS One  2020; 15(1): e0227573.
 [http://dx.doi.org/10.1371/journal.pone.0227573] [PMID:  31923232]

[19]
Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns  2016; 99(6): 926-43.
 [http://dx.doi.org/10.1016/j.pec.2015.11.003] [PMID:  26658704]

[20]
Bukhsh A, Khan TM, Sarfraz Nawaz M, et al. Association of diabetes related self-care activities with glycemic control of patients with type 2 diabetes in Pakistan. Patient Prefer Adherence  2018; 12: 2377-85.
 [http://dx.doi.org/10.2147/PPA.S177314] [PMID:  30519003]

[21]
Bukhsh A, Khan TM, Lee SWH, Lee LH, Chan KG, Goh BH. Efficacy of pharmacist-based diabetes educational interventions on clinical outcomes of adults with type 2 diabetes mellitus: a network meta-analysis. Front Pharmacol  2018; 9: 339.
 [http://dx.doi.org/10.3389/fphar.2018.00339] [PMID:  29692730]

[22]
van Eikenhorst L, Taxis K, van Dijk L, de Gier H. Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Front Pharmacol  2017; 8: 891.
 [http://dx.doi.org/10.3389/fphar.2017.00891] [PMID:  29311916]

[23]
Ho TW, Huang CT, Ruan SY, Tsai YJ, Lai F, Yu CJ. Diabetes mellitus in patients with chronic obstructive pulmonary disease-the impact on mortality. PLoS One  2017; 12(4): e0175794.
 [http://dx.doi.org/10.1371/journal.pone.0175794] [PMID:  28410410]

[24]
Karuppannan M. Malaysian pharmacists’ involvement in pharmaceutical care: A narrative review. Arch PharmPharmacol Res  2019; 2(1): 1-9.
 [http://dx.doi.org/10.33552/APPR.2019.02.000528]

[25]
Shrestha S, Shrestha R, Ahmed A, et al. Impact of pharmacist services on economic, clinical, and humanistic outcome (ECHO) of South Asian patients: A systematic review. J Pharm Policy Pract  2022; 15(1): 37.
 [http://dx.doi.org/10.1186/s40545-022-00431-1] [PMID:  35538500]

[26]
Bukhsh A, Nawaz MS, Ahmed HS, Khan TM. A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients. Medicine  2018; 97(12): e9847.
 [http://dx.doi.org/10.1097/MD.0000000000009847] [PMID:  29561461]

[27]
Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association For The Study Of Diabetes (EASD). Diabetes Care  2018; 41(12): 2669-701.
 [http://dx.doi.org/10.2337/dci18-0033] [PMID:  30291106]

[28]
Esmalipour R, Salary P, Shojaei A. Trust-building in the pharmacist-patient relationship: A qualitative study. Iran J Pharm Res  2021; 20(3): 20-30.
 [PMID:  34903966]

[29]
Cani CG, da Silva Girão Lopes L, Queiroz M, Nery M. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital. Clinics  2015; 70(2): 102-6.
 [http://dx.doi.org/10.6061/clinics/2015(02)06] [PMID:  25789518]

[30]
Larsen DL, Cannon W, Towner S. Longitudinal assessment of a diabetes care management system in an integrated health network. J Manag Care Pharm  2003; 9(6): 552-8.
 [http://dx.doi.org/10.18553/jmcp.2003.9.6.552] [PMID:  14664663]

[31]
Simon MA, Raja BY, Varughese PC, et al. Pharmacist led intervention towards management of type 2 diabetes mellitus and assessment of patient satisfaction of care - A prospective, randomized controlled study. Diabetes Metab Syndr  2021; 15(5): 102208.
 [http://dx.doi.org/10.1016/j.dsx.2021.102208] [PMID:  34298274]

[32]
de Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, de Lyra DP Jr. The 8-item Morisky medication adherence scale: Validation of a Brazilian–Portuguese version in hypertensive adults. Res Social Adm Pharm  2014; 10(3): 554-61.
 [http://dx.doi.org/10.1016/j.sapharm.2013.10.006] [PMID:  24268603]

[33]
Shah JV, Patni KN, Deshpande SS. Achieving glycemic control of diabetic patients through clinical pharmacist provided counseling. J Pharm Sci  2015; 5(3): 322-7.

[34]
Xin C, Xia Z, Jiang C, Lin M, Li G. Effect of pharmaceutical care on medication adherence of patients newly prescribed insulin therapy: A randomized controlled study. Patient Prefer Adherence  2015; 9: 797-802.
 [http://dx.doi.org/10.2147/PPA.S84411] [PMID:  26124646]

[35]
Halalau A, Sonmez M, Uddin A, Karabon P, Scherzer Z, Keeney S. Efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients, a randomized controlled trial-“Pharm-MD”. BMC Endocr Disord  2022; 22(1): 69.
 [http://dx.doi.org/10.1186/s12902-022-00983-y] [PMID:  35296307]

[36]
Orabone AW, Do V, Cohen E. Pharmacist-managed diabetes programs: Improving treatment adherence and patient outcomes. Diabetes Metab Syndr Obes  2022; 15: 1911-23.
 [http://dx.doi.org/10.2147/DMSO.S342936] [PMID:  35757195]

[37]
Zimmermann G, Venkatesan A, Rawlings K, Scahill MD. Improved glycemic control with a digital health intervention in adults with type 2 diabetes: Retrospective study. JMIR Diabetes  2021; 6(2): e28033.
 [http://dx.doi.org/10.2196/28033] [PMID:  34075880]

[38]
Marupuru S, Roether A, Guimond AJ, Stanley C, Pesqueira T, Axon DR. A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. Healthcare  2022; 10(7): 1207.
 [http://dx.doi.org/10.3390/healthcare10071207] [PMID:  35885734]

[39]
Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT. Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open  2013; 3(9): e003154.
 [http://dx.doi.org/10.1136/bmjopen-2013-003154] [PMID:  24068762]

[40]
Foucault-Fruchard L, Bizzoto L, Allemang-Trivalle A, Renoult-Pierre P, Antier D. Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement. Prim Health Care Res Dev  2020; 21: e49.
 [http://dx.doi.org/10.1017/S1463423620000390] [PMID:  33155539]

[41]
Strand L, Cipolle R, Morley P, Frakes M. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des  2004; 10(31): 3987-4001.
 [http://dx.doi.org/10.2174/1381612043382576] [PMID:  15579084]

[42]
von Knoch M, Frosch S, Lehmann W. Arthroscopic reconstruction of intratendinous lesions of the supraspinatus tendon-a systematic review. Z Orthop Unfall  2018; 156(5): 547-53.
 [http://dx.doi.org/10.1055/a-0608-5226] [PMID:  29895091]

[43]
Kennedy-Martin T, Boye K, Peng X. Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Prefer Adherence  2017; 11: 1103-17.
 [http://dx.doi.org/10.2147/PPA.S136639] [PMID:  28721024]

[44]
Ogbonna B, Oparah AC. Impact of pharmaceutical care interventions on type 2 diabetes in a tertiary hospital in Nigeria. Value Health  2016; 19(3): A197.
 [http://dx.doi.org/10.1016/j.jval.2016.03.1312]

[45]
Alsayed AR, Hasoun L, Khader HA, et al. Evaluation of the effectiveness of educational medical informatics tutorial on improving pharmacy students’ knowledge and skills about the clinical problem-solving process. Pharm Pract  2022; 20(2): 01-8.
 [http://dx.doi.org/10.18549/PharmPract.2022.2.2652] [PMID: 35919796]

[46]
Orozco-Beltrán D, Artola S, Jansà M, Lopez de la Torre-Casares M, Fuster E. Impact of hypoglycemic episodes on health-related quality of life of type-2 diabetes mellitus patients: development and validation of a specific QoLHYPO© questionnaire. Health Qual Life Outcomes  2018; 16(1): 52.
 [http://dx.doi.org/10.1186/s12955-018-0875-1] [PMID:  29566707]

[47]
Rashidi A, Naghavi S, Mashayekhi S. Effect of providing pharmaceutical care in diabetes control. J Biol Todays World  2015; 4: 34-43.

[48]
Shaw JE, Sicree RA, Zimmet PZ, Deleq MI, Enaia MI, Nassar SM. Patient disease knowledge and beliefs about medicnes on medication adherence in Palestine. Diabetes Res Clin Pract  2010; 87: 4-14.
 [http://dx.doi.org/10.1016/j.diabres.2009.10.007] [PMID:  19896746]

[49]
Bukhsh A, Tan X, Chan KG, Lee LH, Goh BH, Khan TM. Effectiveness of pharmacist-led educational interventions on self-care activities and glycemic control of type 2 diabetes patients: A systematic review and meta-analysis. Patient Prefer Adherence  2018; 12: 2457-74.
 [http://dx.doi.org/10.2147/PPA.S180256] [PMID:  30538430]

[50]
Witry M, Ernzen M, Pape A, Viyyuri BR. Pilot and feasibility of combining a medication adherence intervention and group diabetes education for patients with type-2 diabetes. Pharmacy  2019; 7(3): 76.
 [http://dx.doi.org/10.3390/pharmacy7030076] [PMID:  31261613]

[51]
Ogbonna BO, Oparah AC. A comprehensive review of pharmaceutical care in type 2 diabetes patients; keeping developing countries in view. Asian J Pharm Res Heal Care  2017; 9: 41-9.

[52]
Tanna N, Tatla T, Winn SJ, et al. Clinical medication review and falls in older people. Pharmcol Pharm Des  2016; 7: 89.

[53]
Ramanath KV, Bhanuprakash M, Nagakishore CH, Kumar SM, Balaji DBSS. Study the clinical phamacist influence on medication adherence & quality of life of rural type-2 diabetes mellitus patients in a tertiary care hospital. Arch Pharm Pract  2012; 3(2): 170.
 [http://dx.doi.org/10.4103/2045-080X.112813]

[54]
Choudhary K, Mali M, Bhaskar K, Pawar S, Diwan A, Barsode S. Effect of pharmaceutical care services provided by clinical pharmacists on type-2 diabetes patients. Journal of Pharmacy Practice and Community Medicine  2019; 5(1): 22-6.
 [http://dx.doi.org/10.5530/jppcm.2019.1.5]

[55]
Chung AYS, Anand S, Wong ICK, et al. Improving medication safety and diabetes management in Hong Kong: A multidisciplinary approach. Hong Kong Med J  2017; 23(2): 158-67.
 [http://dx.doi.org/10.12809/hkmj165014] [PMID:  28302923]

[56]
Hawal NP, Shivaswamy MS, Kambar S, Patil S, Hiremath MB. Knowledge, attitude and behaviour regarding self-care practices among type 2 diabetes mellitus patients residing in an urban area of South India. Int Multidiscip Res J  2012; 2: 31-5.

[57]
Hui RL, Chang CC, Niu F, et al. Evaluation of a pharmacist-managed antidiabetic deprescribing program in an integrated health care system. J Manag Care Spec Pharm  2019; 25(8): 927-34.
 [http://dx.doi.org/10.18553/jmcp.2019.25.8.927] [PMID:  31347983]

[58]
Turk E, Prevolnik Rupel V, Tapajner A, Leyshon S, Isola A. An audit of diabetes-dependent quality of life (ADDQOL) in older patients with diabetes mellitus type 2 in slovenia. Value Health Reg Issues  2013; 2(2): 248-53.
 [http://dx.doi.org/10.1016/j.vhri.2013.05.001] [PMID:  29702872]

[59]
Nyamazana TN, Manyama TM, Tshitake RT. A review on the prevention and management of diabetes mellitus complications and the role of the pharmacist. S Afr Pharm J  2020; 87: 22-5.

[60]
Sealy P, Ignacio D, Legall G. Evaluative research on pharmacist managed diabetes care: Focus on self-monitoring of blood glucose. West Indian Med J  2016; 68: 101.

[61]
Sapkota S, Brien JE, Greenfield JR, Aslani P. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 Diabetes-components of interventions. PLoS One  2015; 10(6): e0128581.
 [http://dx.doi.org/10.1371/journal.pone.0128581] [PMID:  26053004]

[62]
Harvey J. Psychosocial interventions for the diabetic patient. Diabetes Metab Syndr Obes  2015; 8: 29-43.
 [http://dx.doi.org/10.2147/DMSO.S44352] [PMID:  25657590]

[63]
Kelly DV, Young S, Phillips L, Clark D. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can Pharm J  2014; 147(4): 239-47.
 [http://dx.doi.org/10.1177/1715163514535731] [PMID:  25360150]

[64]
Khunti N, Willis A, Davies M, Khunti K. The role of pharmacists in the management of type 2 diabetes: A literature review. Diabetes Prim Care  2013; 15: 131-40.

[65]
Khunkaew S, Fernandez R, Sim J. Demographic and clinical predictors of health-related quality of life among people with type 2 diabetes mellitus living in northern Thailand: A cross-sectional study. Health Qual Life Outcomes  2019; 17(1): 177.
 [http://dx.doi.org/10.1186/s12955-019-1246-2] [PMID:  31796044]

[66]
Shubrook J, Butts A, Chamberlain JJ, Johnson EL, Leal S, Rhinehart AS. Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes  2017; 35(1): 5-26.
 [http://dx.doi.org/10.2337/cd16-0067] [PMID:  28144042]

[67]
Korcegez EI, Sancar M, Demirkan K. Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from northern Cyprus: A randomized controlled trial. J Manag Care Spec Pharm  2017; 23(5): 573-82.
 [http://dx.doi.org/10.18553/jmcp.2017.23.5.573] [PMID:  28448779]

[68]
Habeeb Ibrahim AR, Jose D, Jegan RS. Pharmacists in the wider public health workforce-a review. Arch Pharm Pract  2012; 3(2): 166-9.
 [http://dx.doi.org/10.4103/2045-080X.112812]

[69]
Sinha H. Role of pharmacists in retailing of drugs. J Adv Pharm Technol Res  2014; 5(3): 107.
 [http://dx.doi.org/10.4103/2231-4040.137383] [PMID:  25126530]

[70]
Jing X, Chen J, Dong Y, et al. Related factors of quality of life of type 2 diabetes patients: A systematic review and meta-analysis. Health Qual Life Outcomes  2018; 16(1): 189.
 [http://dx.doi.org/10.1186/s12955-018-1021-9] [PMID:  30231882]

[71]
Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: Current insights. Integr Pharm Res Pract  2017; 6: 37-46.
 [http://dx.doi.org/10.2147/IPRP.S108047] [PMID:  29354549]

[72]
Syarifuddin S, Nasution A, Dalimunthe A. Impact of pharmacist intervention on improving the quality of life of patients with type 2 diabetes mellitus. Open Access Maced J Med Sci  2019; 7(8): 1401-5.
 [http://dx.doi.org/10.3889/oamjms.2019.140] [PMID:  31110593]

[73]
Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-based interventions to improve medication adherence in older adults prescribed polypharmacy: A systematic review. Drugs Aging  2017; 34(2): 97-113.
 [http://dx.doi.org/10.1007/s40266-016-0426-6] [PMID:  28025725]

[74]
Ellis JL, Kovach CR, Fendrich M, et al. Factors related to medication self-management in African American older women. Res Gerontol Nurs  2019; 12(2): 71-9.
 [http://dx.doi.org/10.3928/19404921-20190206-01] [PMID:  30893443]

[75]
Bailey S, Annis I, Reuland D, Locklear A, Sleath B, Wolf M. Development and evaluation of the measure of drugs self-management. Patient Prefer Adherence  2015; 9: 1101-8.
 [http://dx.doi.org/10.2147/PPA.S85411] [PMID:  26257515]

[76]
O’Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ  2008; 336(7654): 1174-7.
 [http://dx.doi.org/10.1136/bmj.39534.571644.BE] [PMID:  18420662]

[77]
Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: A systematic review. Pharmacotherapy  2008; 28(4): 421-36.
 [http://dx.doi.org/10.1592/phco.28.4.421] [PMID:  18363526]

[78]
Wu WC, Taveira TH, Jeffery S, et al. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial. PLoS One  2018; 13(4): e0195898.
 [http://dx.doi.org/10.1371/journal.pone.0195898] [PMID:  29672567]

[79]
Poojar B, Ommurugan B, Adiga S, Thomas H, Sori RK, Poojar B. Methodology used in the study. Asian J Pharm Clin Res  2017; 7: 1-5.

[80]
Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in Southwestern Nigeria. Pharm Pract  2011; 9(2): 72-81.
 [http://dx.doi.org/10.4321/S1886-36552011000200003] [PMID:  24688612]

[81]
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: A systematic review. Diabet Med  2015; 32(6): 725-37.
 [http://dx.doi.org/10.1111/dme.12651] [PMID:  25440507]

[82]
Cazarim MS, de Freitas O, Penaforte TR, Achcar A, Pereira LRL. Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PLoS One  2016; 11(6): e0155204.
 [http://dx.doi.org/10.1371/journal.pone.0155204] [PMID:  27304922]

[83]
Mukta US, Sayka U, Sen Gupta P. How does the type 2 diabetes mellitus patients’compliance to managing diabetics in Bangladesh. OAlib  2015; 02: 1-12.

[84]
Gaddam A, Galla C, Thummisetti S, Marikanty RK, Palanisamy UD, Rao PV. Role of fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. J Diabetes Metab Disord  2015; 14(1): 74.
 [http://dx.doi.org/10.1186/s40200-015-0208-4] [PMID:  26436069]

[85]
Abdi AM, Rasmussen F, Demirdamar R. Impact of introducing clinical pharmacy services in a respiratory diseases clinic: A report from North Cyprus. J Pharm Res Int  2019; 29: 1-15.
 [http://dx.doi.org/10.9734/jpri/2019/v29i630253]
Cite As
Current Diabetes Reviews

An Overview of Pharmaceutical Care in Type II Diabetes Mellitus Patients: Current Position and Prospects

Abstract
